Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ischemic Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 193 articles: HTML format Text format

Single Articles

January 2012
1. FERRANTE G , Presbitero P, Corrada E, Campo G, et al
   Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofi
   Am Heart J. 2012;163:104-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. EISENSTEIN EL , Kong DF, Cowper PA, Bae JP, et al
   Nonfatal myocardial infarction and long-term outcomes in coronary artery disease.
   Am Heart J. 2012;163:95-103.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. DIERCKS DB , Peacock WF 4th, Hollander JE, Singer AJ, et al
   Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain.
   Am Heart J. 2012;163:74-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. VAN DER LAAN AM , Hirsch A, Robbers LF, Nijveldt R, et al
   A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction Monocytes and myocardial infarction.
   Am Heart J. 2012;163:57-65.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. POON S , Goodman SG, Yan RT, Bugiardini R, et al
   Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes.
   Am Heart J. 2012;163:66-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. 
   Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary Embolism Thrombo
   Am Heart J. 2012;163:33-38.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WHITE WB , Grady D, Giudice LC, Berry SM, et al
   A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
   Am Heart J. 2012;163:27-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. JIANG W , Velazquez EJ, Samad Z, Kuchibhatla M, et al
   Responses of mental stress-induced myocardial ischemia to escitalopram treatment: Background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.
   Am Heart J. 2012;163:20-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LAMY A , Devereaux PJ, Prabhakaran D, Hu S, et al
   Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery.
   Am Heart J. 2012;163:1-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
10. BRENER SJ , Cristea E, Mehran R, Dressler O, et al
    Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: The Harmonizing Outcomes with Revascula
    Am Heart J. 2011;162:1044-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MARON DJ , Stone GW, Berman DS, Mancini GB, et al
    Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists.
    Am Heart J. 2011;162:1034-1043.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. HAHN JY , Kim HJ, Choi YJ, Jo SH, et al
    Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2011;162:1026-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KRIM SR , Vivo RP, Krim NR, Cox M, et al
    Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) Registry.
    Am Heart J. 2011;162:988-995.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KRUMHOLZ HM , Curry LA, Bradley EH
    Survival after Acute Myocardial Infarction (SAMI) study: The design and implementation of a positive deviance study.
    Am Heart J. 2011;162:981-987.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. GOMEZ-LARA J , Heo JH, Brugaletta S, Garg S, et al
    Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents.
    Am Heart J. 2011;162:1069-1079.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SHIVARAJU A , Patel V, Fonarow GC, Xie H, et al
    Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: Analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database.
    Am Heart J. 2011;162:1062-1068.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CHIN CT , Weintraub WS, Dai D, Mehta RH, et al
    Trends and predictors of length of stay after primary percutaneous coronary intervention: A report from the CathPCI Registry.
    Am Heart J. 2011;162:1052-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ZIEROLD C , Carlson MA, Obodo UC, Wise E, et al
    Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
    Am Heart J. 2011;162:973-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
19. ROE MT , Chen AY, Thomas L, Wang TY, et al
    Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: The CRUSADE long-term mortality model and risk score.
    Am Heart J. 2011;162:875-883.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GHARACHOLOU SM , Reid KJ, Arnold SV, Spertus J, et al
    Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: Findings from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status registry.
    Am Heart J. 2011;162:860-869.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SCIRICA BM , Bhatt DL, Braunwald E, Steg PG, et al
    The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study.
    Am Heart J. 2011;162:818-825.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. JONES WS , Patel MR, Holleran SA, Harrison JK, et al
    Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
    Am Heart J. 2011;162:932-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. STOLKER JM , Cohen DJ, Lindsey JB, Kennedy KF, et al
    Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.
    Am Heart J. 2011;162:914-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PEACOCK WF , Nagurney J, Birkhahn R, Singer A, et al
    Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum.
    Am Heart J. 2011;162:893-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. MELLONI C , James SK, White JA, Giugliano RP, et al
    Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.
    Am Heart J. 2011;162:884-892.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. 
    Management of acute coronary syndromes in developing countries: ACute Coronary Events-a multinational Survey of current management Strategies.
    Am Heart J. 2011;162:852-859.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CHIN CT , Wang TY, Anstrom KJ, Zhu B, et al
    Treatment with Adenosine Diphosphate Receptor Inhibitors-Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research.
    Am Heart J. 2011;162:844-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KALAVROUZIOTIS D , Buth KJ, Cox JL, Baskett RJ, et al
    Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and beta-blockers after coronary artery bypass graft surgery.
    Am Heart J. 2011;162:836-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. MAURI L , Normand SL, Pencina M, Cutlip DE, et al
    Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
    Am Heart J. 2011;162:826-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. SANZ G , Fuster V, Guzman L, Guglietta A, et al
    The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.
    Am Heart J. 2011;162:811-817.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. NAMMAS W
    Delayed arterial healing 5 years after implantation of sirolimus-eluting stents: no smoke without fire.
    Am Heart J. 2011;162:e29.
    PubMed     Text format     Related articles   
    
    
    
    
32. GUTIERREZ-CHICO JL , Juni P, Garcia-Garcia HM, Regar E, et al
    Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
    Am Heart J. 2011;162:922-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. PUYMIRAT E , Mangiacapra F, Peace A, Sharif F, et al
    Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting.
    Am Heart J. 2011;162:907-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TUNGGAL P , Ng FH, Lam KF, Chan FK, et al
    Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial.
    Am Heart J. 2011;162:870-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
35. SMITH SW , Dodd KW
    Letter to the Editor regarding "Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction".
    Am Heart J. 2011;162:e23.
    PubMed     Text format     Related articles   
    
    
    
    
36. SHAH AM , Hung CL, Shin SH, Skali H, et al
    Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
    Am Heart J. 2011;162:685-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. TRAVERSE JH , Henry TD, Moye' LA
    Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myoca
    Am Heart J. 2011;162:671-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KELLY DJ , Gershlick T, Witzenbichler B, Guagliumi G, et al
    Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial.
    Am Heart J. 2011;162:663-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. POVSIC TJ , O'Connor CM, Henry T, Taussig A, et al
    A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.
    Am Heart J. 2011;162:654-662.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. O'DONOGHUE ML , Braunwald E, White HD, Serruys P, et al
    Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.
    Am Heart J. 2011;162:613-619.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. LAWLER PR , Filion KB, Eisenberg MJ
    Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: A systematic review and meta-analysis of randomized controlled trials.
    Am Heart J. 2011;162:571-584.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KRASUSKI RA , Cater GM, Devendra GP, Wolski K, et al
    Downstream coronary effects of drug-eluting stents.
    Am Heart J. 2011;162:764-771.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SCHWARZ N , Schoenburg M, Mollmann H, Kastaun S, et al
    Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting.
    Am Heart J. 2011;162:756-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. MCMURRAY JJ , Uno H, Jarolim P, Desai AS, et al
    Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
    Am Heart J. 2011;162:748-755.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. KUFNER S , de Waha A, Tomai F, Park SW, et al
    A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
    Am Heart J. 2011;162:740-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. ALEXOPOULOS D , Xanthopoulou I, Davlouros P, Plakomyti TE, et al
    Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel.
    Am Heart J. 2011;162:733-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. VIRANI SS , Woodard LD, Chitwood SS, Landrum CR, et al
    Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease.
    Am Heart J. 2011;162:725-732.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. KASTORINI CM , Milionis HJ, Ioannidi A, Kalantzi K, et al
    Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: A comparative analysis of a case/case-control study.
    Am Heart J. 2011;162:717-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. FLATHER MD , Babalis D, Booth J, Bardaji A, et al
    Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS).
    Am Heart J. 2011;162:700-707.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. PAULY DF , Johnson BD, Anderson RD, Handberg EM, et al
    In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National
    Am Heart J. 2011;162:678-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KRONER BL , Tolunay HE, Basson CT, Pyeritz RE, et al
    The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): Results from phase I and scientific opportunities in phase II.
    Am Heart J. 2011;162:627-632.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. WHITE WB , Bakris GL, Bergenstal RM, Cannon CP, et al
    EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) A cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients
    Am Heart J. 2011;162:620-626.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. RIDKER PM , Thuren T, Zalewski A, Libby P, et al
    Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
    Am Heart J. 2011;162:597-605.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. PIZZI C , Costa GM, Bugiardini R
    Regarding "Depressive symptoms are related to progression of coronary calcium in midlife women: the Study of Women's Health Across the Nation (SWAN) Heart Study".
    Am Heart J. 2011;162:e25.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
55. WELLES CC , Whooley MA, Na B, Ganz P, et al
    The CHADS(2) score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study.
    Am Heart J. 2011;162:555-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. GANG UJ , Jons C, Jorgensen RM, Abildstrom SZ, et al
    Clinical significance of late high-degree atrioventricular block in patients with left ventricular dysfunction after an acute myocardial infarction-A Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) substudy.
    Am Heart J. 2011;162:542-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. KESSLER DP , Kroch E, Hlatky MA
    The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction.
    Am Heart J. 2011;162:494-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ATZEMA CL , Schull MJ, Austin PC, Tu JV, et al
    Temporal changes in emergency department triage of patients with acute myocardial infarction and the effect on outcomes.
    Am Heart J. 2011;162:451-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. SALA C , Grau M, Masia R, Vila J, et al
    Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments.
    Am Heart J. 2011;162:444-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. TYMCHAK W , Armstrong PW, Westerhout CM, Sookram S, et al
    Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: Implications for strategic management.
    Am Heart J. 2011;162:436-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PARIKH PB , Gruberg L, Jeremias A, Chen JJ, et al
    Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.
    Am Heart J. 2011;162:512-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. RONEL J , Mehilli J, Ladwig KH, Blattler H, et al
    Effects of verbal suggestion on coronary arteries: Results of a randomized controlled experimental investigation during coronary angiography.
    Am Heart J. 2011;162:507-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. BAINEY KR , Norris CM, Gupta M, Southern D, et al
    Altered health status and quality of life in South Asians with coronary artery disease.
    Am Heart J. 2011;162:501-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CHAHAL NS , Lim TK, Jain P, Chambers JC, et al
    Does subclinical atherosclerosis burden identify the increased risk of cardiovascular disease mortality among United Kingdom Indian Asians? A population study.
    Am Heart J. 2011;162:460-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SKALI H , Uno H, Levey AS, Inker LA, et al
    Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
    Am Heart J. 2011;162:548-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. HOCHHOLZER W , Trenk D, Mega JL, Morath T, et al
    Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
    Am Heart J. 2011;162:518-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
67. PORTO I , Hamilton-Craig C, De Maria GL, Vergallo R, et al
    Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: Comparison with cardiovascular magnetic resonance.
    Am Heart J. 2011;162:372-381.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. VARENHORST C , Koul S, Erlinge D, Lagerqvist B, et al
    Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study.
    Am Heart J. 2011;162:363-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. SUNDQUIST K , Winkleby M, Li X, Ji J, et al
    Familiar transmission of coronary heart disease: A cohort study of 80,214 Swedish adoptees linked to their biological and adoptive parents.
    Am Heart J. 2011;162:317-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SALISBURY AC , Amin AP, Reid KJ, Wang TY, et al
    Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction.
    Am Heart J. 2011;162:300-309.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. MEDINA HM , Cannon CP, Zhao X, Hernandez AF, et al
    Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: Findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD).
    Am Heart J. 2011;162:283-290.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. RAMANATHAN K , Farkouh ME, Cosmi JE, French JK, et al
    Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction.
    Am Heart J. 2011;162:268-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. RODRIGUEZ F , Joynt KE, Lopez L, Saldana F, et al
    Readmission rates for Hispanic Medicare beneficiaries with heart failure and acute myocardial infarction.
    Am Heart J. 2011;162:254-261.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. ELBAROUNI B , Ismaeil N, Yan RT, Fox KA, et al
    Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Am Heart J. 2011;162:347-355.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. ANDERSON JL , Vanwoerkom RC, Horne BD, Bair TL, et al
    Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?
    Am Heart J. 2011;162:331-339.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. CHANG TI , Shilane D, Brunelli SM, Cheung AK, et al
    Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
    Am Heart J. 2011;162:324-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. BUNEVICIUS A , Stankus A, Brozaitiene J, Girdler SS, et al
    Relationship of fatigue and exercise capacity with emotional and physical state in patients with coronary artery disease admitted for rehabilitation program.
    Am Heart J. 2011;162:310-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. CHAN MY , Shah BR, Gao F, Sim LL, et al
    Recalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian population.
    Am Heart J. 2011;162:291-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HAGE FG , Dean P, Bhatia V, Iqbal F, et al
    The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
    Am Heart J. 2011;162:356-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. BHARDWAJ A , Truong QA, Peacock WF, Yeo KT, et al
    A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.
    Am Heart J. 2011;162:276-282.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. FAYAD ZA , Mani V, Woodward M, Kallend D, et al
    Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Am Heart J. 2011;162:214-221.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
82. WU J , Pride YB, Frederick PD, Gibson CM, et al
    Association of initial Thrombolysis in Myocardial Infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A National Registry of Myocardial Infarction-5
    Am Heart J. 2011;162:178-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. CRISTEA E , Stone GW, Mehran R, Kirtane AJ, et al
    Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: Implications for appropriate stent sizing.
    Am Heart J. 2011;162:173-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. FRENCH JK , Armstrong PW, Cohen E, Kleiman NS, et al
    Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    Am Heart J. 2011;162:89-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KATZ DA , Tang F, Faseru B, Horwitz PA, et al
    Prevalence and correlates of smoking cessation pharmacotherapy in hospitalized smokers with acute myocardial infarction.
    Am Heart J. 2011;162:74-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. PATEL MR , Thiele H, Smalling RW, Chandra P, et al
    A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduc
    Am Heart J. 2011;162:47-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KARAMITSOS TD , Dall'armellina E, Choudhury RP, Neubauer S, et al
    Ischemic heart disease: Comprehensive evaluation by cardiovascular magnetic resonance.
    Am Heart J. 2011;162:16-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MARENZI G , De Metrio M, Bartorelli AL
    Author's reply to Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e9.
    PubMed     Text format     Related articles   
    
    
    
    
89. RAPOSEIRAS-ROUBIN S , Pardal CB, Ocaranza R, Cid B, et al
    Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e7.
    PubMed     Text format     Related articles   
    
    
    
    
90. BIRNBAUM Y , Wilson JM, Nikus K
    Appropriate cardiac catheterization laboratory activation: Optimizing electrocardiogram interpretation and clinical decision making for acute ST-elevation myocardial infarction.
    Am Heart J. 2011;162:e3.
    PubMed     Text format     Related articles   
    
    
    
    
91. LIN GM , Li YH, Chu KM, Han CL, et al
    Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
    Am Heart J. 2011;162:e17.
    PubMed     Text format     Related articles   
    
    
    
    
92. BAYES DE LUNA A , Goldwasser D, de Porta V, Fiol-Sala M, et al
    Optimizing electrocardiographic interpretation in acute ST-elevation myocardial infarction may be very beneficial.
    Am Heart J. 2011;162:e1-2.
    PubMed     Text format     Related articles   
    
    
    
    
93. VOORA D , Horton J, Shah SH, Shaw LK, et al
    Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use.
    Am Heart J. 2011;162:166-172.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BERGER JS , Lala A, Krantz MJ, Baker GS, et al
    Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials.
    Am Heart J. 2011;162:115-124.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. WEBER M , Bazzino O, Navarro Estrada JL, de Miguel R, et al
    Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome.
    Am Heart J. 2011;162:81-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. SHAH SJ , Fonarow GC, Gheorghiade M, Lang RM, et al
    Phase II trials in heart failure: The role of cardiovascular imaging.
    Am Heart J. 2011;162:3-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. CHUNG SC , Hlatky MA, Stone RA, Rana JS, et al
    Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
    Am Heart J. 2011;162:184-192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. BLIDEN KP , Tantry US, Storey RF, Jeong YH, et al
    The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies.
    Am Heart J. 2011;162:160-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. BERGER JS , Bhatt DL, Steg PG, Steinhubl SR, et al
    Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Am Heart J. 2011;162:98-105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
100. PRADA-DELGADO O , Estevez-Loureiro R, Calvino-Santos R, Barge-Caballero E, et al
     Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
     Am Heart J. 2011;161:1207-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. TOUTOUZAS K , Karanasos A, Tsiamis E, Riga M, et al
     New insights by optical coherence tomography into the differences and similarities of culprit ruptured plaque morphology in non-ST-elevation myocardial infarction and ST-elevation myocardial infarction.
     Am Heart J. 2011;161:1192-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. DHILLON OS , Narayan HK, Quinn PA, Squire IB, et al
     Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
     Am Heart J. 2011;161:1163-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. VERMA A , Pfeffer MA, Skali H, Rouleau J, et al
     Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction.
     Am Heart J. 2011;161:1156-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. WILSON SR , Sabatine MS, Wiviott SD, Ray KK, et al
     Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22
     Am Heart J. 2011;161:1147-1155.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. SZEKELY A , Nussmeier NA, Miao Y, Huang K, et al
     A multinational study of the influence of health-related quality of life on in-hospital outcome after coronary artery bypass graft surgery.
     Am Heart J. 2011;161:1179-1185.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. BROUWERS FP , Asselbergs FW, Hillege HL, de Boer RA, et al
     Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
     Am Heart J. 2011;161:1171-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. YAMAMOTO M , Takano M, Murakami D, Inami T, et al
     The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
     Am Heart J. 2011;161:1200-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. JANSSEN I , Powell LH, Matthews KA, Cursio JF, et al
     Depressive symptoms are related to progression of coronary calcium in midlife women: the Study of Women's Health Across the Nation (SWAN) Heart Study.
     Am Heart J. 2011;161:1186-1191.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. VIRANI SS , Woodard LD, Landrum CR, Pietz K, et al
     Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines.
     Am Heart J. 2011;161:1140-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. PERIN EC , Silva GV, Henry TD, Cabreira-Hansen MG, et al
     A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).
     Am Heart J. 2011;161:1078-1087.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. VAN BOMMEL RJ , Ypenburg C, Mollema SA, Borleffs CJ, et al
     Site of latest activation in patients eligible for cardiac resynchronization therapy: Patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.
     Am Heart J. 2011;161:1060-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
112. TAYLOR EN , Rimm EB, Stampfer MJ, Curhan GC, et al
     Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.
     Am Heart J. 2011;161:956-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. LEE DS , Verocai F, Husain M, Al Khdair D, et al
     Cardiovascular outcomes are predicted by exercise-stress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization procedures.
     Am Heart J. 2011;161:900-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. WILLEY JZ , Rodriguez CJ, Carlino RF, Moon YP, et al
     Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.
     Am Heart J. 2011;161:886-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. KONTOS MC , Diercks DB, Ho PM, Wang TY, et al
     Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: Results from the American College of Cardiology's NCDR(R).
     Am Heart J. 2011;161:864-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. GIBSON CM , Mega JL, Burton P, Goto S, et al
     Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, place
     Am Heart J. 2011;161:815-821.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. ALI S , Goodman SG, Yan RT, Budaj A, et al
     Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
     Am Heart J. 2011;161:878-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. ALLEN LAPOINTE NM , Ou FS, Calvert SB, Melloni C, et al
     Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome.
     Am Heart J. 2011;161:855-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. BLOOMFIELD GS , Kimaiyo S, Carter EJ, Binanay C, et al
     Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: An academic model for countering the epidemic.
     Am Heart J. 2011;161:842-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. BURKE MA , Lee R, Fintel DJ
     Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
     Am Heart J. 2011;161:832-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. MAURI L , Leon MB, Yeung AC, Negoita M, et al
     Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial).
     Am Heart J. 2011;161:807-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. SUN JC
     Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
     Am Heart J. 2011;161:e27.
     PubMed     Text format     Related articles   
     
     
     
     
123. REFIKER M
     Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting surgery.
     Am Heart J. 2011;161:e25.
     PubMed     Text format     Related articles   
     
     
     
     
124. BUDANO C , Levis M, D'Amico M, Usmiani T, et al
     Impact of contrast-induced acute kidney injury definition on clinical outcomes.
     Am Heart J. 2011;161:963-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. DAUGHERTY SL , Magid DJ, Kikla JR, Hokanson JE, et al
     Gender differences in the prognostic value of exercise treadmill test characteristics.
     Am Heart J. 2011;161:908-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. CULLEN MW , Reeder GS, Farkouh ME, Kopecky SL, et al
     Outcomes in patients with chest pain evaluated in a chest pain unit: the chest pain evaluation in the emergency room study cohort.
     Am Heart J. 2011;161:871-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. ARMSTRONG PW , Westerhout CM, Van de Werf F, Califf RM, et al
     Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial.
     Am Heart J. 2011;161:848-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. DURANTE A
     The value of elevated high-sensitive troponin T.
     Am Heart J. 2011;161:e33.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
129. MAGRO M , Nauta S, Simsek C, Onuma Y, et al
     Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.
     Am Heart J. 2011;161:771-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. KO DT , Atzema CL, Donovan LR, Graham MM, et al
     Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: A population-based study.
     Am Heart J. 2011;161:764-770.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. KONTOS MC , Aziz HA, Chau VQ, Roberts CS, et al
     Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction.
     Am Heart J. 2011;161:698-704.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. DON CW , Roe MT, Li S, Fraulo E, et al
     Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry.
     Am Heart J. 2011;161:689-97.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. SMILOWITZ NR , Sampson BA, Abrecht CR, Siegfried JS, et al
     Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: An autopsy study.
     Am Heart J. 2011;161:681-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. POWERS BJ , Danus S, Grubber JM, Olsen MK, et al
     The effectiveness of personalized coronary heart disease and stroke risk communication.
     Am Heart J. 2011;161:673-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. NEWELL MC , Henry JT, Henry TD, Duval S, et al
     Impact of age on treatment and outcomes in ST-elevation myocardial infarction.
     Am Heart J. 2011;161:664-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. BRITTON KA , Aggarwal V, Chen AY, Alexander KP, et al
     No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.
     Am Heart J. 2011;161:657-663.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. MONTALESCOT G , Bolognese L, Dudek D, Goldstein P, et al
     A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study.
     Am Heart J. 2011;161:650-656.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. RAMANATH VS , Eagle KA, Nienaber CA, Isselbacher EM, et al
     The role of preoperative coronary angiography in the setting of type A acute aortic dissection: Insights from the International Registry of Acute Aortic Dissection.
     Am Heart J. 2011;161:790-796.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. MEHTA RH , Starr AZ, Lopes RD, Piccini JP, et al
     Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
     Am Heart J. 2011;161:782-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. BEOHAR N , Davidson CJ, Massaro EM, Srinivas VS, et al
     The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
     Am Heart J. 2011;161:755-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. MUNTNER P , Mann D, Wildman RP, Shimbo D, et al
     Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.
     Am Heart J. 2011;161:719-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. BERNHEIM AM , Kittipovanonth M, Takahashi PY, Gharacholou SM, et al
     Does the prognostic value of dobutamine stress echocardiography differ among different age groups?
     Am Heart J. 2011;161:740-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. RAHILLY-TIERNEY C , Sesso HD, Djousse L, Gaziano JM, et al
     Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians.
     Am Heart J. 2011;161:712-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. LIN GM , Li YH, Chu KM, Han CL, et al
     Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy.
     Am Heart J. 2011;161:e17.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
145. LONGMORE RB , Spertus JA, Alexander KP, Gosch K, et al
     Angina frequency after myocardial infarction and quality of life in older versus younger adults: The Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study.
     Am Heart J. 2011;161:631-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. HATOUM IJ , Cook NR, Nelson JJ, Rexrode KM, et al
     Lipoprotein-associated phospholipase A(2) activity improves risk discrimination of incident coronary heart disease among women.
     Am Heart J. 2011;161:516-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. DE BOER SP , Barnes EH, Westerhout CM, Simes RJ, et al
     High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration.
     Am Heart J. 2011;161:500-507.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. TRACHTENBERG B , Velazquez DL, Williams AR, McNiece I, et al
     Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-b
     Am Heart J. 2011;161:487-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. GIBSON CM , Maehara A, Lansky AJ, Wohrle J, et al
     Rationale and design of the INFUSE-AMI study: A 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST
     Am Heart J. 2011;161:478-486.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. UDELSON JE , Pearte CA, Kimmelstiel CD, Kruk M, et al
     The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
     Am Heart J. 2011;161:611-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. SARAFOFF N , Neumann L, Morath T, Bernlochner I, et al
     Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting.
     Am Heart J. 2011;161:605-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. GOEL K , Thomas RJ, Squires RW, Coutinho T, et al
     Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease.
     Am Heart J. 2011;161:590-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. KUKULA K , Chojnowska L, Dabrowski M, Witkowski A, et al
     Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
     Am Heart J. 2011;161:581-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. ARZAMENDI D , Benito B, Tizon-Marcos H, Flores J, et al
     Increase in sudden death from coronary artery disease in young adults.
     Am Heart J. 2011;161:574-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. ARAGAM KG , Moscucci M, Smith DE, Riba AL, et al
     Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary intervention.
     Am Heart J. 2011;161:544-551.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. 
     The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study par
     Am Heart J. 2011;161:538-543.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. RADUNOVIC Z , Wekre LL, Diep LM, Steine K, et al
     Cardiovascular abnormalities in adults with osteogenesis imperfecta.
     Am Heart J. 2011;161:523-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. MCDANIEL MC , Galbraith EM, Jeroudi AM, Kashlan OR, et al
     Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: Relation to bifurcations and curvatures.
     Am Heart J. 2011;161:508-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. 
     The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Athero
     Am Heart J. 2011;161:471-477.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. CAPODANNO D , Tamburino C
     Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions.
     Am Heart J. 2011;161:462-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. VAMADEVAN AS , Shah BR, Califf RM, Prabhakaran D, et al
     Cardiovascular research in India: A perspective.
     Am Heart J. 2011;161:431-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. BOYTSOV S , Van de Werf F
     Regional challenges and opportunities in cardiovascular research: The Russian Federation "SWOT" analysis.
     Am Heart J. 2011;161:427-30.
     PubMed     Text format     Related articles   
     
     
     
     
163. GURBEL PA , Shuldiner AR, Bliden KP, Ryan K, et al
     The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy.
     Am Heart J. 2011;161:598-604.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. SHANKS M , Delgado V, Ng AC, Auger D, et al
     Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy.
     Am Heart J. 2011;161:552-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. WHITE HD
     Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
     Am Heart J. 2011;161:450-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. SCHRAMM W , Notley B
     The ancient and often incorrect units for the ventricular stroke work should be replaced by an SI unit.
     Am Heart J. 2011;161:e9.
     PubMed     Text format     Related articles   
     
     
     
     February 2011
167. HAKIM DA , Dangas GD, Caixeta A, Nikolsky E, et al
     Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORI
     Am Heart J. 2011;161:391-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. CHOI CU , Rha SW, Oh DJ, Poddar KL, et al
     Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
     Am Heart J. 2011;161:373-382.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. EDWARDS J , Goodman SG, Yan RT, Welsh RC, et al
     Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early beta-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE).
     Am Heart J. 2011;161:291-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. WESTERHOUT CM , Bonnefoy E, Welsh RC, Steg PG, et al
     The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.
     Am Heart J. 2011;161:283-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. TARANTINI G , Van de Werf F, Bilato C, Gersh B, et al
     Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delay.
     Am Heart J. 2011;161:247-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. CRUDEN NL , Morch K, Wong DR, Klinke WP, et al
     Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting.
     Am Heart J. 2011;161:404-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. HOLPER EM , Abbott JD, Mulukutla S, Vlachos H, et al
     Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
     Am Heart J. 2011;161:397-403.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. KO YG , Suh JW, Kim BH, Lee CJ, et al
     Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention.
     Am Heart J. 2011;161:383-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. KWON SW , Kim BK, Kim TH, Kim JS, et al
     Qualitative assessment of neointimal tissue after drug-eluting stent implantation: Comparison between follow-up optical coherence tomography and intravascular ultrasound.
     Am Heart J. 2011;161:367-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. BRILAKIS ES , Cohen DJ, Kleiman NS, Pencina M, et al
     Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: Results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry.
     Am Heart J. 2011;161:360-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. BOVE AA , Santamore WP, Homko C, Kashem A, et al
     Reducing cardiovascular disease risk in medically underserved urban and rural communities.
     Am Heart J. 2011;161:351-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. FEDELE S , Sabbah W, Donos N, Porter S, et al
     Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US survey.
     Am Heart J. 2011;161:344-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. CAIXETA A , Dangas GD, Mehran R, Feit F, et al
     Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
     Am Heart J. 2011;161:298-306.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. BALCI A , Sollie KM, Mulder BJ, de Laat MW, et al
     Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study.
     Am Heart J. 2011;161:269-275.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. POVSIC TJ , Cohen MG, Mehran R, Buller CE, et al
     A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: Design and rationale of the RADAR Ph
     Am Heart J. 2011;161:261-268.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. JOLLY SS , Niemela K, Xavier D, Widimsky P, et al
     Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes.
     Am Heart J. 2011;161:254-260.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. JAVED U , Deedwania PC, Bhatt DL, Cannon CP, et al
     Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
     Am Heart J. 2011;161:418-424.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. POSTMA S , Dambrink JH, de Boer MJ, Gosselink AT, et al
     Prehospital triage in the ambulance reduces infarct size and improves clinical outcome.
     Am Heart J. 2011;161:276-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
185. DEVLIN G , Reynolds HR, Mark DB, Rankin JM, et al
     Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).
     Am Heart J. 2011;161:84-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. COLLET JP , Cayla G, Cuisset T, Elhadad S, et al
     Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopido
     Am Heart J. 2011;161:5-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. SEREBRUANY VL
     Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial?
     Am Heart J. 2011;161:1-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
188. LONBORG J , Holmvang L, Kelbaek H, Vejlstrup N, et al
     ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance.
     Am Heart J. 2010;160:1085-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. HEESTERMANS T , van 't Hof AW, ten Berg JM, van Werkum JW, et al
     The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
     Am Heart J. 2010;160:1079-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. PORTO I , Hamilton-Craig C, Brancati M, Burzotta F, et al
     Angiographic assessment of microvascular perfusion-Myocardial blush in clinical practice.
     Am Heart J. 2010;160:1015-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. LOZANO I , Barriales V, Rondan J, Suarez C, et al
     Elevation of high-sensitivity cardiac troponin T and composite end points in randomized trials.
     Am Heart J. 2010;160:e47.
     PubMed     Text format     Related articles   
     
     
     
     November 2010
192. HASSAN A , Newman A, Ko DT, Rinfret S, et al
     Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005.
     Am Heart J. 2010;160:958-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. BERNHEIM SM , Wang Y, Bradley EH, Masoudi FA, et al
     Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures.
     Am Heart J. 2010;160:943-950.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: